Ayurvedic Medicine for the Treatment of Dementia: Mechanistic Aspects
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Ayurvedic medicine is a personalized system of traditional medicine native to India and the Indian subcontinent. It is based on a holistic view of treatment which promotes and supports equilibrium in different aspects of human life: the body, mind, and soul. Popular Ayurvedic medicinal plants and formulations that are used to slow down brain aging and enhance memory include Ashwagandha (Withania somnifera), Turmeric (Curcuma longa), Brahmi (Bacopa monnieri), Shankhpushpi (Convolvulus pluricaulis, Evolvulus alsinoides, and other species), gotu kola (Centella asiatica), and guggulu (Commiphora mukul and related species) and a formulation known as Brāhmī Gh ṛ ita, containing Brahmi, Vacā (Acorus calamus), Ku ṣṭ ha (Saussurea lappa), Shankhpushpi, and Purāṇa Gh ṛ ita (old clarified butter/old ghee). The rationale for the utilization of Ayurvedic medicinal plants has depended mostly on traditional usage, with little scientific data on signal transduction processes, efficacy, and safety. However, in recent years, pharmacological and toxicological studies have begun to be published and receive attention from scientists for verification of their claimed pharmacological and therapeutic effects. The purpose of this review is to outline the molecular mechanisms, signal transduction processes, and sites of action of some Ayurvedic medicinal plants. It is hoped that this description can be further explored with modern scientific methods, to reveal new therapeutic leads and jump‐start more studies on the use of Ayurvedic medicine for prevention and treatment of dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336 · cited 3×
“Both in vitro and in vivo studies indicate that curcumin binds with Aβ and inhibits its aggregation [43, 47], as well as fibril and oligomer formation [43].”
BackgroundMcShane, R., Areosa Sastre, A., & Minakaran, N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003154.pub5 · Cited by 1,155
Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia: A Review of the Evidence
Sink, K. M., Holden, K. F., & Yaffe, K. (2005) · JAMA · doi:10.1001/jama.293.5.596 · Cited by 910
An Overview on Ashwagandha: A Rasayana (Rejuvenator) of Ayurveda
Singh, N., Bhalla, M., De Jager, P., & Gilca, M. (2011) · African Journal of Traditional, Complementary and Alternative Medicines · doi:10.4314/ajtcam.v8i5s.9 · Cited by 544 · cited 2×
“The beneficial effects of Ashwagandha root constituents in neurodegenerative diseases may be due to their neurite promoting, antioxidant, anti-inflammatory, antiapoptotic, and anxiolytic activities, as well as their ability to improve mitochondrial dysfunction and restore energy levels and increase levels of antioxida…”
BackgroundMa, Q.-L., Yang, F., Rosario, E. R., Ubeda, O. J., Beech, W., Gant, D. J., Chen, P. P., Hudspeth, B., Chen, C., Zhao, Y., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1071-09.2009 · Cited by 536 · cited 1×
“In vivo studies have shown that dietary curcumin not only crosses the blood-brain barrier and decreases Aβ deposition in AD transgenic mice [43], but also markedly inhibits Tau phosphorylation [48].”
BackgroundBacopa monniera, a reputed nootropic plant: An overview
Russo, A., & Borrelli, F. (2005) · Phytomedicine · doi:10.1016/j.phymed.2003.12.008 · Cited by 447 · cited 1×
“However, it is reported that Brāhmı̄ Gh ita may act not only by reversing cholinergic deficits in the frontal cortex and hippocampus [73], but also via alleviating cholinergic neurodegeneration [74], lowering norepinephrine, and increasing 5-hydroxytryptamine levels in the hippocampus, hypothalamus, and cerebral corte…”
BackgroundThe Ayurvedic medicine Clitoria ternatea—From traditional use to scientific assessment
Mukherjee, P. K., Kumar, V., Kumar, N. S., & Heinrich, M. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.09.009 · Cited by 369
Cox, K. H., Pipingas, A., & Scholey, A. B. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114552744 · Cited by 368
Vascular cognitive impairment: current concepts and clinical developments
Moorhouse, P., & Rockwood, K. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70040-1 · Cited by 358
C., S., P., N., J., L., J., C., C., H., L., D., & T., R. (2001) · Psychopharmacology · doi:10.1007/s002130100815 · Cited by 342
Neuritic regeneration and synaptic reconstruction induced by withanolide A
Kuboyama, T., Tohda, C., & Komatsu, K. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706122 · Cited by 339 · cited 2×
“Moreover, treatment of cultured rat cortical neurons with Aβ (25–35) (10 μM) produces axonal and dendritic atrophy and pre- and postsynaptic loss, and these changes were abrogated by treatment with WL-A (1 μM) [37].”
BackgroundChronic Effects of Brahmi (Bacopa monnieri) on Human Memory
Roodenrys, S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00419-5 · Cited by 313 · cited 2×
“Bacopa monnieri treatment for 3 months decreases the rate of forgetting of newly acquired information in human subjects between 40 and 65 years of age [55].”
BackgroundNeuroleptic drugs in dementia: benefits and harm
Ballard, C., & Howard, R. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1926 · Cited by 308
Calabrese, C., Gregory, W. L., Leo, M., Kraemer, D., Bone, K., & Oken, B. (2008) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2008.0018 · Cited by 301 · cited 1×
“Standardized Bacopa monnieri extract treatment (300mg/day) for 12 weeks improves performance in a delayed recall and Stroop Task (assessing the ability to ignore irrelevant information), in participants without dementia aged 65 and above [66].”
MethodChoudhary, D., Bhattacharyya, S., & Bose, S. (2017) · Journal of Dietary Supplements · doi:10.1080/19390211.2017.1284970 · Cited by 215
Haloperidol for agitation in dementia
Lonergan, E., Luxenberg, J., Colford, J. M., & Birks, J. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002852 · Cited by 212
Ven Murthy, M. R., K. Ranjekar, P., Ramassamy, C., & Deshpande, M. (2010) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524911006030238 · Cited by 178
Dhanasekaran, M., Holcomb, L. A., Hitt, A. R., Tharakan, B., Porter, J. W., Young, K. A., & Manyam, B. V. (2009) · Phytotherapy Research · doi:10.1002/ptr.2405 · Cited by 175
Hogan, D. B., Bailey, P., Black, S., Carswell, A., Chertkow, H., Clarke, B., Cohen, C., Fisk, J. D., Forbes, D., Man-Son-Hing, M., et al. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.081103 · Cited by 167
Neurocognitive Effect of Nootropic Drug Brahmi (Bacopa monnieri) in Alzheimer's Disease
Chaudhari, K. S., Tiwari, N. R., Tiwari, R. R., & Sharma, R. S. (2017) · Annals of Neurosciences · doi:10.1159/000475900 · Cited by 167
Morgan, A., & Stevens, J. (2010) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2009.0342 · Cited by 156 · cited 1×
“Moreover, treatment with Bacopa monnieri (300mg/day) improves verbal learning, memory acquisition, and delayed recall in healthy volunteers over 55 years of age [67].”
BackgroundStough, C., Downey, L. A., Lloyd, J., Silber, B., Redman, S., Hutchison, C., Wesnes, K., & Nathan, P. J. (2008) · Phytotherapy Research · doi:10.1002/ptr.2537 · Cited by 141 · cited 1×
“Bacopa monnieri (2 × 150mg) treatment for 90 days improves performance in a spatial working memory task in healthy humans [64, 65].”
BackgroundEffects of Ashwagandha (Roots of Withania somnifera) on Neurodegenerative Diseases
Kuboyama, T., Tohda, C., & Komatsu, K. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00022 · Cited by 127 · cited 1×
“Ashwagandha is a safe herb [39, 40], although a few people experience diarrhea or nausea after consuming the root.”
BackgroundPerluigi, M., Joshi, G., Sultana, R., Calabrese, V., De Marco, C., Coccia, R., Cini, C., & Butterfield, D. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20879 · Cited by 125 · cited 1×
“Guggulu contains ferulic acids, phenols, and other nonphenolic aromatic acids which are potent scavengers of superoxide radicals and can be important for the treatment of neurodegenerative diseases that are associated with oxidative stress [101, 102].”
BackgroundClitoria ternatea root extract enhances acetylcholine content in rat hippocampus
Rai, K. S., Murthy, K. D., Karanth, K. S., Nalini, K., Rao, M. S., & Srinivasan, K. K. (2002) · Fitoterapia · doi:10.1016/s0367-326x(02)00249-6 · Cited by 113 · cited 2×
“The administration of ethanolic extracts of Shankhpushpi increases acetylcholine content in fields CA1 and CA3 of the hippocampus in a dose-dependent manner [85, 86].”
BackgroundMorley, J. E., & Banks, W. A. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091576 · Cited by 108
Sun, G. Y., Li, R., Cui, J., Hannink, M., Gu, Z., Fritsche, K. L., Lubahn, D. B., & Simonyi, A. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8411-0 · Cited by 95 · cited 1×
“It is suggested that WL-A activates the translocation of Nrf2 to the nucleus, where the transcription factor upregulates the expression of neuroprotective proteins, such as heme oxygenase-1 [34, 35].”
BackgroundNahata, A., Patil, U. K., & Dixit, V. K. (2008) · Natural Product Research · doi:10.1080/14786410802214199 · Cited by 74 · cited 2×
“Convolvulus pluricaulis has been shown to improve learning and memory in rodents [68].”
BackgroundPractical guidelines for the acute emergency sedation of the severely agitated older patient
Peisah, C., Chan, D. K. Y., McKay, R., Kurrle, S. E., & Reutens, S. G. (2011) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02560.x · Cited by 55
Pharmacological studies on bacopa monniera, an Ayurvedic nootropic agent
Dhawan, B. N., & Singh, H. K. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)87969-7 · Cited by 37
Beneficial effect of Brahmi Ghrita on learning and memory in normal rat
Yadav, K., Reddy, K. R. C., & Kumar, V. (2014) · AYU (An International Quarterly Journal of Research in Ayurveda) · doi:10.4103/0974-8520.153755 · Cited by 28
Cited by
Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
Rawat, P., Sehar, U., Bisht, J., Selman, A., Culberson, J., & Reddy, P. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112841 · Cited by 509
“Curcumin also reduces the pro-inflammatory cycle by blocking the proliferation of TNF-α, IL-1β, and other proinflammatory cytokines in astrocytes and microglia [231].”
BackgroundCardiovascular Protective Effects of Centella asiatica and Its Triterpenes: A Review
Razali, N. N. M., Ng, C. T., & Fong, L. Y. (2019) · Planta Medica · doi:10.1055/a-1008-6138 · Cited by 95
Bansal, K., Bhati, H., Vanshita, & Bajpai, M. (2024) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2024.100403 · Cited by 37
Alzheimer’s Disease and Herbal Combination Therapy: A Comprehensive Review
Pradeep, S., Jain, A. S., Dharmashekara, C., Prasad, S. K., Kollur, S. P., Syed, A., & Shivamallu, C. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200228 · Cited by 30
The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment
Zieneldien, T., Kim, J., & Cao, C. (2022) · Geriatrics · doi:10.3390/geriatrics7020024 · Cited by 29
Metadata
- Authors
- Farooqui, A. A., Farooqui, T., Madan, A., Ong, J. H.-J., & Ong, W.-Y.
- Venue
- Evidence-Based Complementary and Alternative Medicine
- Publisher
- Wiley
- Published
- 2018-01
- Volume
- 2018
- Issue
- 1
- Pages
- 2481076-2481076
- ISSN
- 1741-427X (ISSN-L)
- 1741-4288
- OpenAlex
- W2804324197
- Cited by
- 138
- References
- 31
- FWCI
- 16.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.